4//SEC Filing
Shah Tushar 4
Accession 0001104659-21-138343
CIK 0001819576other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 9:03 PM ET
Size
16.9 KB
Accession
0001104659-21-138343
Insider Transaction Report
Form 4
Liquidia CorpLQDA
Shah Tushar
CMO and Head of R&D
Transactions
- Tax Payment
Common Stock
2021-11-12$5.04/sh−487$2,457→ 50,763 total - Tax Payment
Common Stock
2021-11-12$4.90/sh−11,882$58,204→ 38,881 total - Exercise/Conversion
Common Stock
2021-11-10+51,250→ 51,250 total - Award
Performance Stock Units
2021-11-10−51,250→ 0 total→ Common Stock (51,250 underlying)
Footnotes (2)
- [F1]Each performance stock unit (PSU) converts into one share of common stock of the Issuer.
- [F2]On January 19, 2021, the reporting person was granted 51,250 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861.
Issuer
Liquidia Corp
CIK 0001819576
Entity typeother
Related Parties
1- filerCIK 0001487632
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 9:03 PM ET
- Size
- 16.9 KB